Phoenix Pharmaceuticals, Inc.

Company Overview

Phoenix Pharmaceuticals, Inc. is a US manufacturer of research-grade peptides and immunoassay reagents serving universities, government laboratories, hospital research centers, CROs and pharmaceutical R&D groups worldwide. Founded in 1994 by Dr. Jaw-Kang Chang, who first synthesized TRH in 1969, and headquartered in Burlingame, California, the company is ISO 9001 certified and manufactures 100% of its peptides in the USA; European institutional customers are supported by Phoenix Europe GmbH in Karlsruhe, Germany. Its catalog spans more than 9,200 reagents, including over 4,054 peptides organized across 315 peptide families and 94 species, together with labeled peptides (biotin, fluorescent, radioactive and stable-isotope labeled), peptide libraries, polyclonal antibodies and ELISA/EIA/RIA kits. Peptides are supplied at >=98% purity by HPLC with mass-spectrometry identity confirmation, and a Certificate of Analysis (CoA) is included with every order; custom synthesis covers peptides up to 112 amino acids. Orders ship worldwide via FedEx (some items on dry ice) to more than 40 countries. First-time orders require a verified institutional account and products are restricted to in vitro and preclinical laboratory research; not for human consumption.

Business Details

Key Features & Certifications

Hot Peptides

Products (55)